Frontiers in Cell and Developmental Biology | |
Extracellular Vesicles and Transforming Growth Factor β Signaling in Cancer | |
Dorival Mendes Rodrigues-Junior1  Aristidis Moustakas1  Carl-Henrik Heldin1  Chrysoula Tsirigoti1  Sai Kiang Lim2  | |
[1] Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden;Institute of Molecular and Cell Biology (A*-STAR), Singapore, Singapore; | |
关键词: cancer-associated fibroblast (CAF); epithelial – mesenchymal transition (EMT); extracellular vesicle (EV); metastasis; micro-RNA (miRNA); transforming growth factor β (TGF-β); | |
DOI : 10.3389/fcell.2022.849938 | |
来源: DOAJ |
【 摘 要 】
Complexity in mechanisms that drive cancer development and progression is exemplified by the transforming growth factor β (TGF-β) signaling pathway, which suppresses early-stage hyperplasia, yet assists aggressive tumors to achieve metastasis. Of note, several molecules, including mRNAs, non-coding RNAs, and proteins known to be associated with the TGF-β pathway have been reported as constituents in the cargo of extracellular vesicles (EVs). EVs are secreted vesicles delimited by a lipid bilayer and play critical functions in intercellular communication, including regulation of the tumor microenvironment and cancer development. Thus, this review aims at summarizing the impact of EVs on TGF-β signaling by focusing on mechanisms by which EV cargo can influence tumorigenesis, metastatic spread, immune evasion and response to anti-cancer treatment. Moreover, we emphasize the potential of TGF-β-related molecules present in circulating EVs as useful biomarkers of prognosis, diagnosis, and prediction of response to treatment in cancer patients.
【 授权许可】
Unknown